PubMed:32881190 / 892-1114
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"19","span":{"begin":38,"end":46},"obj":"Species"}],"attributes":[{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The probability to visit asymptomatic patients passed from 1.2% (95% confidence interval -95CI, 0.6-2.5%) in the first period (20 February-15 March 2020) to 11.1% (95CI, 5.8-23.6%) in the second period (16 March-30 April)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":0,"end":222},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The probability to visit asymptomatic patients passed from 1.2% (95% confidence interval -95CI, 0.6-2.5%) in the first period (20 February-15 March 2020) to 11.1% (95CI, 5.8-23.6%) in the second period (16 March-30 April)."}